The U.S. Food and Drug Administration (FDA) cleared Admedus’s CardioCel, a tissue product to repair and treat a range of cardiovascular and vascular defects. The company is looking to complement its existing product launch in Europe with preparation for initial sales in the United States.

The University of Michigan’s Center for Integrative Research in Critical Care (MCIRCC) has entered into a letter of intent with AirStrip with the goal of executing future collaborations, and MedStar Health has entered into a collaboration agreement with AirStrip. Both agreements are part of the AirStrip Innovation Marketplace (AIM) Program.

Scripps Green Hospital has become the first hospital in the United States to implant the world's smallest implantable cardiac monitoring device. Scripps Clinic cardiologist John Rogers, M.D., successfully completed the first implant of the Reveal Linq Insertable Cardiac Monitor (ICM) in 71-year-old San Diego resident Chuck Beal.

AliveCor Inc. announced a partnership with Practice Fusion, a physician-patient community. Physician offices will now be able to import the AliveCor Heart Monitor’s ECG readings, annotated reports and reviews into the Practice Fusion HER. It an attempt to allow them to see a more complete picture of their patients’ medical history and make more educated treatment decisions. Practice Fusion's EHR is used by more than 100,000 medical professionals on a monthly basis, and all of whom will now be offered the ability to import AliveCor ECGs directly into their EHR. Through the AliveECG app physicians can record a patient’s ECG, obtain an expert review, annotate and electronically transfer this data into the EHR within seconds.

Cordis Corp. announced an agreement with TriReme Medical Inc. that grants the company exclusive distribution rights for the Chocolate PTA Balloon Catheter. 

The U.S. Food and Drug Administration (FDA) approved Biosense Webster Inc.’s Thermocool Smarttouch Catheter. The therapeutic catheter enables direct and real-time measurement of contact force during catheter ablation procedures for patients suffering from drug-resistant paroxysmal atrial fibrillation (Afib), sustained monomorphic ischemic ventricular tachycardia and Type I atrial flutter.


Determining the appropriate use of cardiovascular imaging requires analyzing the “complex interplay” among care processes and their quality, patient health outcomes and medical costs, according to a health policy statement released by the American College of Cardiology and endorsed by 14 other relevant medical societies. 


February 28, 2014 — Lexmark’s Perceptive Software demonstrated its Universal Clinical Platform solution for enterprise clinical content management at the 2014 meeting of the Healthcare Information and Management Systems Society (HIMSS).

Subscribe Now